Moderna and Pfizer's Covid-19 vaccines should be administered instead of Johnson & Johnson's one-dose shot because of the higher risk of blood clot associated with it, according to a Centers For Disease Control and Prevention advisory board.
The Johnson & Johnson COVID-19 vaccine was approved by the U.S. FDA and was used at the event put on by the Thornton Fire Department.
The images are from the same company.
According to the Wall Street Journal, fifteen members of the Advisory Committee on Immunization Practices voted unanimously to recommend the Pfizer and Moderna MRNA vaccines after hearing that the incidence of blood clot from the J&J shot was higher than previously known.
Nine of the 54 cases of TTS that occurred in people who received the J&J vaccine were fatal.
The CDC has to make a decision on whether or not to accept the recommendation, though it does not prevent providers from giving out the J&J shot.
Continue watching after the ad Visit Advertiser website.
Helen Keipp Talbot said the committee was concerned about the additional TTS cases.
The number is big.
About 16 million people. The J&J shot has been given to 73 million people in the U.S., compared to 114 million who have received Moderna's, according to the CDC.
The key background.
The CDC suspended the use of the J&J vaccine in April to investigate six cases of TTS. The J&J shot has been linked to a rare neurological disorder. The CDC advised those who got the J&J shot to get a booster dose, as well as those who got two doses of Pfizer and Moderna's vaccine. According to the New York Times, only a small percentage of people choose to get the J&J vaccine as their booster shot.
FDA To Warn, Johnson & Johnson Vaccine Could Raise Risk.
CDC Advisors Back Booster Shots for Moderna.
